WallStSmart

Kenvue Inc. (KVUE)vsUSANA Health Sciences Inc (USNA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 1535% more annual revenue ($15.12B vs $925.26M). KVUE leads profitability with a 9.7% profit margin vs 1.2%. USNA appears more attractively valued with a PEG of 0.81. KVUE earns a higher WallStSmart Score of 58/100 (C).

KVUE

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 6.5Value: 4.7Quality: 4.5
Piotroski: 3/9Altman Z: 1.22

USNA

Buy

54

out of 100

Grade: C-

Growth: 3.3Profit: 5.0Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUESignificantly Overvalued (-15.9%)

Margin of Safety

-15.9%

Fair Value

$16.00

Current Price

$17.53

$1.53 premium

UndervaluedFair: $16.00Overvalued
USNAUndervalued (+73.0%)

Margin of Safety

+73.0%

Fair Value

$77.70

Current Price

$19.05

$58.65 discount

UndervaluedFair: $77.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE0 strengths · Avg: 0/10

No standout strengths identified

USNA2 strengths · Avg: 9.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

PEG RatioValuation
0.818/10

Growing faster than its price suggests

Areas to Watch

KVUE3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.2%4/10

3.2% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

USNA4 concerns · Avg: 3.3/10
P/E RatioValuation
33.7x4/10

Premium valuation, high expectations priced in

Market CapQuality
$360.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.0%3/10

ROE of 2.0% — below average capital efficiency

Profit MarginProfitability
1.2%3/10

1.2% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

PEG of 1.48 suggests the stock is reasonably priced for its growth.

Bull Case : USNA

The strongest argument for USNA centers on Price/Book, PEG Ratio. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Piotroski F-Score, Altman Z-Score.

Bear Case : USNA

The primary concerns for USNA are P/E Ratio, Market Cap, Return on Equity. Thin 1.2% margins leave little buffer for downturns.

Key Dynamics to Monitor

USNA carries more volatility with a beta of 0.70 — expect wider price swings.

USNA is growing revenue faster at 5.9% — sustainability is the question.

KVUE generates stronger free cash flow (744M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KVUE scores higher overall (58/100 vs 54/100). USNA offers better value entry with a 73.0% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

USANA Health Sciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company is headquartered in Salt Lake City, Utah.

Want to dig deeper into these stocks?